Somalia
Tuberculosis profile
| High HIV burden |
Population  2012 10 million
Estimates of TB burden * 2012 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 6.5 (2.5–12) 64 (25–120)
Mortality (HIV+TB only) 0.43 (0.38–0.48) 4.2 (3.7–4.7)
Prevalence  (includes HIV+TB) 59 (29–99) 581 (287–975)
Incidence  (includes HIV+TB) 29 (24–35) 286 (236–340)
Incidence (HIV+TB only) 0.85 (0.7–1) 8.3 (6.9–9.9)
Case detection, all forms (%) 41 (34–50)    
TB case notifications 2012        
New cases   (%) Retreatment cases (%)
Smear-positive 6 127 (53) Relapse 389 (56)
Smear-negative 1 739 (15) Treatment after failure 106 (15)
Smear-unknown / not done 1 449 (13) Treatment after default 16 (2)
Extrapulmonary 2 271 (20) Other 188 (27)
Other 0 (0)      
Total new 11 586   Total retreatment 699  
           
Other (history unknown) 0        
Total new and relapse 11 975   Total cases notified 12 285  
New cases Smear-positive Smear-negative/ unknown/
not done
Extrapulmonary
M:F ratio 1.8 1.5 1.3
Age < 15 250 1 630 484
Laboratories 2012
Smear (per 100 000 population) 0.6
Culture (per 5 million population) 0
Drug susceptibility testing (per 5 million population) 0
Is second-line drug susceptibility testing available? No
Treatment success rate 2011 (%)        
New smear-positive and/or culture-positive 86   Is rifampicin used
throughout treatment for
new patients?
Yes
New smear-negative/extrapulmonary 86  
Retreatment 72  
TB/HIV 2012 Number (%)
TB patients with known HIV status 5 359 (44)
HIV-positive TB patients 192 (4)
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT) 151 (79)
HIV-positive TB patients on antiretroviral therapy (ART) 51 (27)
HIV-positive people screened for TB 674  
HIV-positive people provided with IPT    
Estimates of MDR-TB burden 2012*   New   Retreatment
% of TB cases with MDR-TB 5.2 (2.7–7.7) 41 (23–58)
MDR-TB cases among notified pulmonary
TB cases
480 (250–720) 280 (160–410)
Reported cases of MDR-TB 2012 New Retreatment Total
Cases tested for MDR-TB 0 (0%) 0 (0%) 0
Laboratory-confirmed MDR-TB cases 0 0 0
Patients started on MDR-TB treatment     0
Financing TB control 2013
National TB programme budget (US$ millions) 48
% Funded domestically 0%
% Funded internationally 100%
% Unfunded 0%
***
(Rate per 100 000 population per year)
Mortality graph
___ Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
___ Prevalence

(Rate per 100 000 population per year)
Incidence graph
__ Notifications Incidence
___
___ Incidence (HIV+TB only)

Treatment success rate (%)
tx success graph
__ New smear-positive and/or culture-positive
__ New smear-negative/extrapulmonary __
Retreatment

(Number of patients)
CPT ART graph
__ HIV-positive TB patients
__ on CPT __ on ART

Total budget (US$ millions)
Budget funding Graph
__ Funded domestically __ Funded internationally
__ Unfunded
 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 * Ranges represent uncertainty intervals Generated: 2014-04-18 Data: www.who.int/tb/data